Active Ingredient History

  • Now
Moricizine is an antiarrhythmic agent previously marketed as Ethmozine. It was used for prophylaxis and treatment of serious and life-threatening ventricular arrhythmias. In 2007 it was withdrawn and discontinued for commercial reasons. Moricizine can be administered intravenously but was more commonly provided as an oral formulation.   NCATS

  • SMILES: CCOC(=O)Nc1ccc2Sc3ccccc3N(C(=O)CCN4CCOCC4)c2c1
  • Mol. Mass: 427.53
  • ALogP: 4.11
  • ChEMBL Molecules:
More Chemistry
[10-(3-morpholin-4-yl-propionyl)-10h-phenothiazin-2-yl]-carbamic acid ethyl ester | en-313 | ethmozin | ethmozine | ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate | ethyl 10-(beta-n-morpholinylpropionyl)phenothiazine-2-carbamate | etmozin | moracizin | moracizina | moracizine | moracizine hydrochloride | moracizinum | moricizine | moricizine hcl | moricizine hydrochloride


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue